S H Kelkar and Company share price
NSE: SHKChemicalsSpecialty Chemicals
S H Kelkar and Company at a glance
S H Kelkar and Company (NSE: SHK) closed at ₹131.67 on 22 Oct 2026, down 0.51% on the day. With a market capitalisation of ₹1,823 Cr, it ranks 1181st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.
At its last close the stock traded at 26.3× trailing earnings, against a return on equity of 5.1% in FY26. Over the past year the share price has fallen 39.5%. Its 52-week range is ₹111.98 (30 Mar 2026) to ₹231.28 (23 Oct 2025); the last close is 43.1% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹660 Cr (+14.0% year on year) and net profit ₹46 Cr (+81.7%), on a consolidated basis. Promoters held 54.87% of the company as of 30 Jun 2026; 8.30% of promoter shares were pledged.
Key numbers
- Market cap
- ₹1,823 CrRank 1181 on NSE
- P/E (trailing)
- 26.3×
- Price to book
- 1.14×FY26
- EPS (TTM)
- ₹6.43to Q1 FY27
- ROE
- 5.1%FY26
- ROCE
- 7.5%FY26
- Debt to equity
- 0.62FY26
- Net profit margin
- 2.9%FY26
- Book value / share
- ₹98.39FY26
- Dividend payout
- 40.0%FY26
- 52-week high
- ₹231.2823 Oct 2025
- 52-week low
- ₹111.9830 Mar 2026
- 1-year return
- −39.5%
- RSI (14-day)
- 38.8
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.51% | −4.2% | −3.1% | −5.0% | −39.5% |
S H Kelkar and Company quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹543 Cr | ₹541 Cr | ₹564 Cr | ₹579 Cr | ₹552 Cr | ₹581 Cr | ₹647 Cr | ₹660 Cr |
| Revenue YoY | +19.1% | +9.0% | +5.9% | +23.0% | +1.7% | +7.5% | +14.7% | +14.0% |
| Net profit | ₹40 Cr | ₹18 Cr | ₹102 Cr | ₹25 Cr | ₹9 Cr | ₹33 Cr | ₹1 Cr | ₹46 Cr |
| Net profit YoY | +34.2% | −42.7% | +206.1% | — | −76.6% | +81.4% | −99.2% | +81.7% |
| Net margin | 7.5% | 3.4% | 18.1% | 4.4% | 1.7% | 5.7% | 0.1% | 7.0% |
| EPS | ₹2.87 | ₹1.27 | ₹7.41 | ₹1.85 | ₹0.66 | ₹2.36 | ₹0.13 | ₹3.28 |
S H Kelkar and Company financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹1,322 Cr | ₹1,564 Cr | ₹1,687 Cr | ₹1,930 Cr | ₹2,123 Cr | — |
| Operating profit | ₹181 Cr | ₹144 Cr | ₹125 Cr | ₹182 Cr | ₹177 Cr | — |
| Net profit | ₹144 Cr | ₹149 Cr | ₹63 Cr | ₹124 Cr | ₹74 Cr | — |
| EPS (₹) | ₹10.00 | ₹11.00 | ₹5.00 | ₹9.00 | ₹5.00 | — |
| Cash from operations | ₹195 Cr | ₹50 Cr | ₹197 Cr | ₹107 Cr | ₹16 Cr | — |
| Total debt | ₹332 Cr | ₹363 Cr | ₹319 Cr | ₹173 Cr | ₹175 Cr | ₹212 Cr |
| Shareholders' equity | ₹952 Cr | ₹1,013 Cr | ₹1,064 Cr | ₹1,213 Cr | ₹1,272 Cr | ₹1,362 Cr |
S H Kelkar and Company shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.48% | 55.03% | 54.87% | 54.87% | 54.87% | 54.87% |
| Foreign institutions | 7.22% | 6.96% | 7.36% | 6.79% | 7.42% | 5.92% |
| Domestic institutions | 3.44% | 3.37% | 5.69% | 6.02% | 5.18% | 6.01% |
| Non-institutions | 33.87% | 34.64% | 32.08% | 32.33% | 32.53% | 33.21% |
| Promoter shares pledged | 5.60% | 0.56% | 5.66% | 5.66% | 8.30% | 8.30% |
S H Kelkar and Company vs peers
The listed Chemicals companies nearest to S H Kelkar and Company by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| OALOriental Aromatics | ₹605.80 | +1.27% | +83.7% | ₹2,039 Cr | — | — |
| BODALCHEMBodal Chemicals | ₹150.00 | −3.85% | +147.1% | ₹1,889 Cr | 39.5 | — |
| INDOKEMIndokem | ₹673.85 | −0.92% | — | ₹1,879 Cr | — | — |
| SHKS H Kelkar and Company | ₹131.67 | −0.51% | −39.5% | ₹1,823 Cr | 26.3 | — |
| IGPLIG Petrochemicals | ₹555.00 | +2.60% | +35.0% | ₹1,709 Cr | — | — |
| GOCLCORPGOCL Corporation | ₹343.10 | −0.78% | +4.2% | ₹1,701 Cr | 6.1 | — |
| CAMLINFINECamlin Fine Sciences | ₹85.67 | −1.42% | −54.9% | ₹1,646 Cr | — | — |
Ask anything about S H Kelkar and Company
Pivot answers on the live chart with evidence you can check, and tests strategies against SHK's own history. Try: “Why has SHK moved over the last three months?” · “Backtest a 50-day moving-average crossover on SHK over five years” · “Compare SHK with OAL on margins and valuation”
Frequently asked questions about S H Kelkar and Company
What is the share price of S H Kelkar and Company today?
S H Kelkar and Company (NSE: SHK) last closed at ₹131.67 on 22 Oct 2026. Its 52-week high is ₹231.28 and its 52-week low is ₹111.98.
What is the market cap of S H Kelkar and Company?
S H Kelkar and Company's market capitalisation is ₹1,823 Cr (₹1,823 Cr) at the 22 Oct 2026 close, ranking 1181st among the NSE companies Pivot tracks.
What is the P/E ratio of S H Kelkar and Company?
S H Kelkar and Company trades at a trailing P/E of 26.3.
What is the ROE and ROCE of S H Kelkar and Company?
Return on equity was 5.1% in FY26 and return on capital employed was 7.5% in FY26 (consolidated figures).
Is S H Kelkar and Company a debt-free company?
No. S H Kelkar and Company's debt-to-equity ratio was 0.62 in FY26, with total debt of ₹212 Cr.
What were S H Kelkar and Company's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), S H Kelkar and Company reported revenue of ₹660 Cr, +14.0% year on year, and net profit of ₹46 Cr, +81.7% year on year.
How has S H Kelkar and Company stock performed over the last year?
S H Kelkar and Company's share price has fallen 39.5% over the past year, −5.0% over three months and −3.1% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of S H Kelkar and Company?
As of 30 Jun 2026: promoters 54.87%, foreign institutions 5.92%, domestic institutions 6.01%, non-institutions 33.21%. 8.30% of promoter shares were pledged.
Who are S H Kelkar and Company's competitors?
The listed Chemicals companies closest to S H Kelkar and Company by market cap are Oriental Aromatics, Bodal Chemicals, Indokem, IG Petrochemicals, GOCL Corporation and Camlin Fine Sciences.
Is S H Kelkar and Company a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out S H Kelkar and Company's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SHK against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Chemicals stocks · companies starting with S · all NSE stocks · this page as text